DecisionX for Pharma
A trial signal, a batch disposition, and a launch call are the same decision chain, not three separate reviews. This is where DecisionX connects R&D, Manufacturing, and Commercial into one traceable story.
One decision, three functions
Most cross-functional problems aren't three separate issues,they're one signal that never stayed connected. Here's how the same anomaly moves through R&D, Manufacturing, and Commercial without being re-diagnosed at each handoff.
A secondary endpoint in Trial 3 reveals an unexpected interaction with a commonly prescribed comorbidity medication.
The same evidence automatically flags the affected production lot for expanded stability testing before release.
Launch messaging and physician-facing claims are held until the stability evidence is complete, not questioned after launch.
How DecisionX reasons
Every signal above, trial, stability, or launch, moves through the same reasoning arc before it becomes a decision. This is the operating model underneath R&D, Manufacturing, and Commercial.
The three pillars
Each pillar below runs its own full decision lifecycle in depth on its own page. Here's the summary of what each one owns.
Trial, pipeline, and regulatory decisions grounded in a traceable evidence chain.
Batch disposition, deviation, and yield decisions built on production data.
Launch, HCP engagement, and access decisions grounded in commercial signals.
The System
The root cause found in R&D doesn't get re-investigated in Manufacturing.
Commercial finds out about a quality hold before launch, not after.
A regulator or auditor can trace one decision across all three functions.
Decision AI for Pharma
See DecisionX connect your trial, plant, and launch data. First value in 15 days.